Brief: Heat Biologics Says Covid-19 Vaccine Demonstrates Immunogenicity Proof-Of-Concept In Pre-Clinical Studies
29/07/2020 12:55
July 29 (Reuters) - Heat Biologics Inc HTBX.O :
* HEAT BIOLOGICS INC - HEAT BIOLOGICS COVID-19 VACCINE
DEMONSTRATES IMMUNOGENICITY PROOF-OF-CONCEPT IN PRE-CLINICAL
STUDIES
* HEAT BIOLOGICS - CONFIRMS STIMULATION OF
HUMAN-HLA-RESTRICTED
TRANSGENIC MOUSE T-CELLS AGAINST IMMUNODOMINANT EPITOPES OF
SARS-COV-2 SPIKE PROTEIN
Source : (https://bit.ly/33bJEg9)
Further company coverage: HTBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scorpius Holdings
See all newsBrief: Scorpius Holdings Inc Files For Non Timely 10-K With U.S. SEC
Brief: Scorpius Holdings Files For Offering Up To 29.4 Million Shares Of Common Stock
Brief: Scorpius Holdings Announces Collaboration With Celltheon Corporation
Brief: Scorpius Holdings - Implementation Of Strategic Cost-Saving Measures Expected To Save Over $2 Mln Annually
Brief: Scorpius Holdings Announces Partnership With U.S. Biotech Company